Picture of Kopin logo

KOPN — Kopin News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMid CapNeutral

Microdisplays maker Kopin Q3 revenue misses expectations

Overview

Kopin Q3 revenue misses analyst expectations, adjusted EPS beats estimates

Net income for Q3 exceeds analyst estimates, reflecting improved financial performance

Company forms strategic partnerships to expand international market access

Outlook

Kopin expects to grow aggressively in U.S. and international markets

Company notes increased defense budgets in U.S., EU, and Southeast Asia

Kopin highlights $41 mln private placement to support strategic growth

Result Drivers

STRATEGIC PARTNERSHIPS - Kopin cites partnerships with Theon Sensors, Ondas Holdings, and Unusual Machines as key to expanding international market access and U.S. defense applications

MICROLED DEVELOPMENT - Transformative color MicroLED development order with U.S. Army funded by IBAS program seen as a growth driver

THERMAL WEAPON SIGHTS - Increased sales from products used in thermal weapon sights partially offset revenue declines

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueMiss$12 mln$13.50 mln (3 Analysts)
Q3 EPSBeat$0.02-$0.01 (2 Analysts)
Q3 Net IncomeBeat$4.10 mln-$2.09 mln (2 Analysts)
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the semiconductors peer group is "buy" Wall Street's median 12-month price target for Kopin Corp is $4.25, about 34.1% above its November 11 closing price of $2.80 Press Release: ID:nBw55gvQFa For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Kopin

See all news